About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Lombard Cohort of Brain Health Services | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNCT07457138

Lombard Cohort of Brain Health Services

The goal of this multicenter prospective observational cohort study is to better understand the clinical, neuropsychological, and biological characteristics of individuals attending Brain Health Servi...

Lead sponsor: University of Milano Bicocca•5 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Federico Emanuele Pozzi, MD

CONTACT

+393494113421 federicoemanuele.pozzi@gmail.com

Sponsors

Lead Sponsor

University of Milano Bicocca

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Adults (≥18 years)
•Diagnosis of SCD, FCD, or "well worried" individuals without objective cognitive impairment
•Evaluation at one of the Lombardy BHS
•Ability to provide written informed consent

Exclusion Criteria

•Diagnosis of mild cognitive impairment or dementia at baseline visit
•Enrollment in another interventional study with an expected effect on cognition
•Pregnancy or breastfeeding

Related studies

RECRUITINGPhase 2

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

NCT07033494 · Early Alzheimer's Disease

RECRUITINGPhase 2/3

ACP-204 in Adults With Alzheimer's Disease Psychosis

NCT06159673 · Alzheimer's Disease Psychosis

RECRUITINGPhase 1

A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease

NCT07214727 · Alzheimer's Disease

RECRUITINGPhase 3

Evaluate the Use of [18F]-APN-1607 PET in Subjects With AD-related Cognitive Impairment and Subjects With Normal Cognitive Function

NCT07422857 · Subjects With Mild Cognitive Impairment (MCI) of AD, Alzheimer's Disease (AD) Dementia

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

NCT06584357 · Mild Cognitive Impairment, Alzheimer's Disease, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 17, 2026Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment1,000

Start dateFeb 2026

Last updatedMar 17, 2026

Condition

Subjective Cognitive Decline (SCD)Functional Cognitive Disorder Alzheimer's Disease Brain Health

Locations shown

Villa Beretta Rehabilitation Center

Costa Masnaga, Lombardy

IRCCS Auxologico

Milan, Lombardy

IRCCS Don Gnocchi

Milan, Lombardy

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 17, 2026Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions